Device Trial Radar · NCT03859440
Three-month Clinical Evaluation of DSiHy Daily Disposable Silicone Hydrogel Contact Lenses
Last checked: Nov 20, 2026Latest source record: Mar 7, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
90
Planned (sponsor's estimate)
Start
May 2019
Primary completion
Oct 2019
Study completion Oct 2019
Sponsor
- Lead sponsor
- HOYA Lamphun LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 1, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the clinical performance of two daily disposable silicone hydrogel contact lenses. One of these lenses, the 'test' lens is an investigational product. This means that it has not yet been approved for commercial use and is not available for sale. The other lens (control) is a commercially available contact lens. The results of this study will be analysed to determine how the 'test' lens compares with the 'control' lens. The control lens has been chosen because it is a market leader and is well tried and tested. Participants who are in this study will need to have healthy eyes, except for the need to correct their eyesight. Up to 90 people who are aged 20 years or older will be considered for participation in this study. The study is designed to be approximately 3 months long.
Conditions
- Contact Lenses
Interventions
DSiHy Silicone hydrogel soft contact lensDevice
•Device: DSiHy (test lens) Silicone hydrogel soft contact lens for daily disposable wear.
CE-marked Silicone hydrogel soft contact lensDevice
・Device: Silicone hydrogel soft contact lens CE-marked for daily disposable wear. Other Name : MyDay
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lens-related ocular adverse events requiring temporary or permanent discontinuation (resting eyes) as a proportion of follow-up eye examinations.Time frame: 13 week visit
2 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.